(Q28195312)

https://api.crossref.org/works/10.2165%2F00002512-200623010-00001

Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623010-00001

The Correlation of Arteriosclerosis Obliterans with Lipoproteins in Insulin-Dependent and Non-Insulin-Dependent Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623010-00001

Treatment of older persons with hypercholesterolemia with and without cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623010-00001

Should hypercholesterolemia in older persons be treated to reduce cardiovascular events?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623010-00001

Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623010-00001

Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623010-00001

Mortality over four years in SHEP participants with a low ankle-arm index

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623010-00001

Arteriosclerosis Obliterans: Review of 520 Cases with Special Reference to Pathogenic and Prognostic Factors

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623010-00001

Elderly diabetics with peripheral arterial disease and no coronary artery disease have a higher incidence of new coronary events than elderly nondiabetics with peripheral arterial disease and prior myocardial infarction treated with statins and with

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623010-00001

Incidence of new atherothrombotic brain infarction in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol >or=125 mg/dl treated with statins versus no lipid-lowering drug

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623010-00001

Reduction of new coronary events and new atherothrombotic brain infarction in older persons with diabetes mellitus, prior myocardial infarction, and serum low-density lipoprotein cholesterol >/=125 mg/dl treated with statins

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623010-00001

Underutilization of aspirin, beta blockers, angiotensin-converting enzyme inhibitors, and lipid-lowering drugs and overutilization of calcium channel blockers in older persons with coronary artery disease in an academic nursing home

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623010-00001

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623010-00001

Subclinical hypothyroidism is associated with coronary artery disease in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623010-00001

Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: a meta-analysis of phase III multicenter randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623010-00001

Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623010-00001

State-of-the-Art lecture. Statins and blockers of the renin-angiotensin system: vascular protection beyond their primary mode of action

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623010-00001

Conservative management of intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623010-00001

Chelation therapy for peripheral arterial occlusive disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623010-00001

Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study

21 January 2018

1 reference

12 December 2020

Effect of nicotine chewing gum in combination with group counseling on the cessation of smoking

1 reference

12 December 2020

Prevalence of severe arteriosclerosis obliterans in patients with diabetes mellitus. Relation to smoking and form of therapy

1 reference

12 December 2020

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

12 December 2020

Influence of coronary heart disease on morbidity and mortality after lower extremity revascularization surgery: a population-based study in Olmsted County, Minnesota (1970-1987)

1 reference

12 December 2020

Peripheral arterial disease in the elderly: The Rotterdam Study

1 reference

12 December 2020

Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment

1 reference

12 December 2020

Relation of decreased ankle-brachial index to prevalence of atherosclerotic risk factors, coronary artery disease, aortic valve calcium, and mitral annular calcium.

1 reference

12 December 2020

Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000.

1 reference

12 December 2020

Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease

1 reference

12 December 2020

Drug treatment of peripheral vascular disease.

1 reference

12 December 2020

The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study.

1 reference

12 December 2020

The measured effect of stopping smoking on intermittent claudication

1 reference

12 December 2020

Association of valvular aortic stenosis with symptomatic peripheral arterial disease in older persons

1 reference

12 December 2020

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

1 reference

12 December 2020

Tobacco smoking, nicotine, and nicotine and non-nicotine replacement therapies

1 reference

12 December 2020

Commentary on "Embracing complexity: A consideration of hypertension in the very old"

1 reference

12 December 2020

Risk factors for symptomatic peripheral arterial disease in older persons in an academic hospital-based geriatrics practice

1 reference

12 December 2020

Prognostic significance of silent ischemia in elderly patients with peripheral arterial disease with and without previous myocardial infarction

1 reference

12 December 2020

Increased prevalence of peripheral arterial disease in older men and women with subclinical hypothyroidism

1 reference

12 December 2020

Treatment of intermittent claudication with antiplatelet agents

1 reference

12 December 2020

Mortality over a period of 10 years in patients with peripheral arterial disease

1 reference

12 December 2020

Correlation of serum lipids with the presence or absence of atherothrombotic brain infarction and peripheral arterial disease in 1,834 men and women aged > or = 62 years

1 reference

12 December 2020

Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease

1 reference

12 December 2020

Results of EMATAP: a double-blind placebo-controlled multicentre trial of ticlopidine in patients with peripheral arterial disease

1 reference

12 December 2020

PGE1 and other prostaglandins in the treatment of intermittent claudication: a meta-analysis

1 reference

12 December 2020

What is the appropriate treatment of hypertension in elders?

1 reference

12 December 2020

Management of peripheral arterial disease

1 reference

12 December 2020

Meta-analysis of randomised controlled prostaglandin E1 studies in peripheral arterial occlusive disease stages III and IV.

1 reference

12 December 2020

Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease

1 reference

12 December 2020

Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease. A prospective double-blind arteriographically controlled trial

1 reference

12 December 2020

Intermittent claudication: prevalence and risk factors

1 reference

12 December 2020

The action of ticlopidine on human platelets. Studies on aggregation, secretion, calcium mobilization and membrane glycoproteins

1 reference

12 December 2020

Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes

1 reference

12 December 2020

Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study

1 reference

12 December 2020

Multicenter double-blind study of ticlopidine in the treatment of intermittent claudication and the prevention of its complications

1 reference

12 December 2020

Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease

1 reference

12 December 2020

Medical treatment of peripheral arterial disease and claudication

1 reference

12 December 2020

Effect of simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at six months and at one year after treatment

1 reference

12 December 2020

Incidence of new coronary events in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug

1 reference

12 December 2020

Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase

1 reference

12 December 2020

Frequency of new coronary events in older persons with peripheral arterial disease and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug

1 reference

12 December 2020

Clinical characteristics, risk factors, and medical treatment of 561 patients with peripheral arterial disease followed in an academic vascular surgery clinic

1 reference

12 December 2020

Frequency of congestive heart failure in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug

1 reference

12 December 2020

Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women > or = 62 years of age.

1 reference

12 December 2020

Prevalence of symptomatic peripheral arterial disease, modifiable risk factors, and appropriate use of drugs in the treatment of peripheral arterial disease in older persons seen in a university general medicine clinic

1 reference

12 December 2020

Intermittent claudication and subsequent cardiovascular disease in the elderly

1 reference

12 December 2020

Association of ankle-brachial index with severity of angiographic coronary artery disease in patients with peripheral arterial disease and coronary artery disease

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Decreased ankle/arm blood pressure index and mortality in elderly women

1 reference

12 December 2020

AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update

1 reference

12 December 2020

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

1 reference

12 December 2020

Association of mitral annular calcium with symptomatic peripheral arterial disease in older persons

1 reference

12 December 2020

Prevalence and incidence of cardiovascular disease in 1160 older men and 2464 older women in a long-term health care facility

1 reference

12 December 2020

Reduction of homocysteine levels in coronary artery disease by low-dose folic acid combined with vitamins B6 and B12

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

12 December 2020

Effect of an ongoing educational program on the use of antiplatelet drugs, beta-blockers, angiotensin-converting enzyme inhibitors, and lipid-lowering drugs in patients with coronary artery disease seen in an academic cardiology clinic

1 reference

12 December 2020

Prevalence of atherothrombotic brain infarction, coronary artery disease and peripheral arterial disease in elderly blacks, Hispanics and whites

1 reference

12 December 2020

Utilization of lipid-lowering drugs in elderly persons with increased serum low-density lipoprotein cholesterol associated with coronary artery disease, symptomatic peripheral arterial disease, prior stroke, or diabetes mellitus before and after an

1 reference

12 December 2020

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

12 December 2020

The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein

1 reference

12 December 2020

Combination antiplatelet therapy in patients with peripheral vascular bypass grafts

1 reference

12 December 2020

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

12 December 2020

Treating tobacco addiction--nicotine or no nicotine?

1 reference

12 December 2020

Prevalence of left main coronary artery disease, of three- or four-vessel coronary artery disease, and of obstructive coronary artery disease in patients with and without peripheral arterial disease undergoing coronary angiography for suspected coro

1 reference

12 December 2020

Treatment of intermittent claudication with beraprost sodium, an orally active prostaglandin I2 analogue: a double-blinded, randomized, controlled trial

1 reference

12 December 2020

Prevalence of intermittent claudication and its effect on mortality

1 reference

12 December 2020

Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and symptomatic peripheral arterial disease

1 reference

12 December 2020

Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial

1 reference

12 December 2020

The association of dyslipoproteinemia with symptoms and signs of peripheral arterial disease. The Lipid Research Clinics Program Prevalence Study

1 reference

12 December 2020

Drug therapy: vasodilator drugs in peripheral vascular disease

1 reference

12 December 2020

Long-term survival in patients with coronary artery disease: importance of peripheral vascular disease. The Coronary Artery Surgery Study (CASS) Investigators

1 reference

12 December 2020

Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients

1 reference

12 December 2020

Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S)

1 reference

12 December 2020

Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease

1 reference

12 December 2020

Association between plasma homocysteine and peripheral arterial disease in older persons

1 reference

12 December 2020

A comparison of cilostazol and pentoxifylline for treating intermittent claudication

1 reference

12 December 2020

Low-dose aspirin and subsequent peripheral arterial surgery in the Physicians' Health Study

1 reference

12 December 2020

Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease

1 reference

12 December 2020

Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication

1 reference

12 December 2020

A comparison of sustained-release bupropion and placebo for smoking cessation

1 reference

12 December 2020

Hyperhomocysteinemia: an independent risk factor for vascular disease

1 reference

12 December 2020

Prostanoids for intermittent claudication

1 reference

12 December 2020

The effect of smoking on the late patency of arterial reconstructions in the legs

1 reference

12 December 2020

Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial

1 reference

12 December 2020

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

12 December 2020

Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials

1 reference

12 December 2020

Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease

1 reference

12 December 2020

Prevalence of peripheral arterial disease and its correlation with risk factors for peripheral arterial disease in elderly patients in a long-term health care facility

1 reference

12 December 2020

The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease

1 reference

12 December 2020

Propionyl-l-carnitine in intermittent claudication: Double-blind, placebo-controlled, dose titration, multicenter study

1 reference

12 December 2020

Estimation of peripheral arteriosclerotic disease by ankle blood pressure measurements in a population study of 60-year-old men and women

1 reference

12 December 2020

Sex differences in peripheral arterial disease: leg symptoms and physical functioning

1 reference

12 December 2020

Naftidrofuryl in intermittent claudication: a retrospective analysis.

1 reference

12 December 2020